Floatz logo

Evomela

Enteropathy-Associated T-Cell Lymphoma

Eric Jacobsen, MDPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Enteropathy-Associated T-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Inno-206
Eric Jacobsen, MD
Phase 4BBB
ETOPOSIDE
Eric Jacobsen, MD
Phase 4BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BBB
PREDNISONE TABLETS
Eric Jacobsen, MD
Phase 4BB
Ifosfamide
Shandong Provincial Hospital
Phase 4BB

View all 36 →

Same molecule, other indications

Evomela is also rated in:

diffuse large B-cell lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
76 / 100
View asset →
myeloproliferative neoplasmDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →